Sven Hellberg
11Patents
5h-index
13Co-inventors
52Inventor score
Filing activity: Feb 18, 2002 → Sep 21, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7595319B2 | Compounds having selective inhibiting effect at GSK3 | Chemistry; Metallurgy | 9 | Expired |
| US7205314B2 | Compounds for the treatment of dementia related diseases | Chemistry; Metallurgy | 7 | Expired |
| US7399780B2 | 3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3 | Chemistry; Metallurgy | 6 | Expired |
| US7342022B2 | Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3 | Chemistry; Metallurgy | 6 | Expired |
| US7078410B2 | 2-arylamino-pyrimidines for the treatment of GSK3-related disorders | Human Necessities | 5 | Expired |
| US7585853B2 | Compounds having selective inhibiting effect at GSK3 | Human Necessities | 2 | Expired |
| US7595321B2 | Compounds having selective inhibiting effect at GSK3 | Chemistry; Metallurgy | 2 | Expired |
| US6747060B2 | Non-natural galanin receptor ligands | Human Necessities | 1 | Expired |
| US7056939B2 | 4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3) | Human Necessities | 1 | Expired |
| US7345050B2 | Pyrimidine compounds | Human Necessities | 0 | Expired |
| US7683067B2 | 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3) | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.